๐ŸŒŸ Stock of the Week: Apollo Hospitals Enterprise Ltd.

๐Ÿ—“๏ธ GoalFi Stock of the Week | 17 August 2025

Hello ,

Each week, we spotlight one stock thatโ€™s delivering strong returns backed by robust fundamentals and market momentum. This weekโ€™s focus is Apollo Hospitals Enterprise Ltd.

๐ŸŒŸ Stock of the Week: Apollo Hospitals Enterprise Ltd.

๐Ÿฅ About the Company

Founded in 1983, the company operates one of Asiaโ€™s most comprehensive private healthcare platforms spanning hospitals, pharmacies, primary care, diagnostics, and retail health models across India.

๐Ÿ” Why Apollo Hospitals is Buzzing Right Now

โœ… Quality compounder at scale: TTM sales โ‚น22,550 Cr, operating profit โ‚น3,199 Cr, OPM 14%
โœ… Profitability up YoY: TTM EPS โ‚น109.43; last-year ROE 18%
โœ… Heavy institutional ownership: FIIs 43.49%, DIIs 21.34% (Jun-25)
โœ… Balance sheet comfort: D/E 0.96; Debt โ‚น7,864 Cr with strong operating cash generation

Tune in for practical investment advice that anyone can apply, whether you're a beginner or looking to enhance your existing portfolio.

๐Ÿ“Š Performance Snapshot

Metric

Value

Last Traded Price

โ‚น7,822

Market Cap

โ‚น1,12,461 Cr

P/E

71.5

Book Value / P/B

โ‚น571 / 13.7x

EV / EBITDA

34.6x

Dividend Yield

0.24%

Promoter / FII / DII / Public

29.34% / 43.49% / 21.34% / 5.61%

๐Ÿ’ผ Quarterly & Annual Financials

TTM (from P&L)

Sales

Operating Profit

OPM

PBT

Net Profit

EPS

โ‚น22,550 Cr

โ‚น3,199 Cr

14%

โ‚น2,192 Cr

โ‚น1,631 Cr

โ‚น109.43

Last 4 Quarters (Consolidated)

Quarter

Sales (โ‚น Cr)

OPM %

Net Profit (โ‚น Cr)

EPS (โ‚น)

Jun 2025

5,842

15%

441

30.10

Mar 2025

5,592

14%

414

27.10

Dec 2024

5,527

14%

379

25.89

Sep 2024

5,589

15%

396

26.34

๐Ÿงพ Key Operating Ratios

ROCE

ROE

ROIC

OPM (latest qtr)

NPM (latest qtr)

Sales Growth

16.6%

18.4%

14.9%

14.6%

7.55%

14.3%

๐Ÿ“Œ Portfolio Representation

Portfolio Name

Entry Price

Weight

Return (%)

Rebalance Date

Tourism Titans & Other Portfolios

โ‚น6,649.4

8%

+17.63

Mar 2025

๐Ÿ“ข A Note to Our Investors

Dear Investors,

As we step into the mid August, we're feeling positive about the road ahead.
๐Ÿ“ˆ Market valuations are reasonable, and we believe the Indian equity markets are well-positioned for a bounce-back once the current uncertainty clears.

Yes, the recent weeks may have tested patience - but this is part of the equity journey. Don't worry or panic. Staying invested is what builds long-term wealth. ๐Ÿ’ช

Your portfolios are carefully built with some of the finest companies in the Indian market, selected as per your chosen strategy.

๐Ÿ‘‰ If you're under-invested, consider topping up.
๐Ÿ‘‰ If you're already fully invested, just give your investments time to grow - like a tree that will one day bear fruit for you and your family. ๐ŸŒณ

Stay calm, stay invested, and let compounding do the magic. โœจ

๐Ÿ“ฉ Reach us via chat.goalfi.app โœ‰ Email: [email protected]

๐Ÿง  GoalFi View

A scale leader in organized healthcare with improving unit economics and strong institutional sponsorship. With steady margin traction, high-quality cash flows, and sustained demand for tertiary care and adjacencies (pharmacy, diagnostics), Apollo continues to fit a quality-at-scale + compounding thesis.

๐Ÿ“ข GoalFi Announcement

Weโ€™re expanding our GoalFi WhatsApp Community for our valued subscribers!

If youโ€™re a subscriber but not yet part of the community, weโ€™d be happy to welcome you in.

Get access to:
โœ”๏ธ Daily research updates
โœ”๏ธ Market insights
โœ”๏ธ Live alerts
โœ”๏ธ Direct analyst communication

๐Ÿ“ฉ To join, simply message us at ๐Ÿ‘‰ chat.goalfi.app

Letโ€™s build smarter investing habits, together.
https://goalfiresearch.smallcase.com

We hope this update helps you stay informed and empowered in your investment journey. Feel free to reach out if you have any questions or need personalized advice.

Best Regards,
Team GoalFi

Disclaimer: This newsletter is intended solely for educational and informational use. It does not constitute financial advice or serve as a promotional message.